Cargando…
Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients
ABSTRACT: Tacrolimus is a calcineurin inhibitor used to prevent acute graft versus host disease in adult patients receiving allogeneic hematopoietic stem cell transplantation (HCT). Previous population pharmacokinetic (PK) models have been developed in solid organ transplant, yet none exists for pat...
Autores principales: | Zhu, Jing, Campagne, Olivia, Torrice, Chad D., Flynn, Gabrielle, Miller, Jordan A., Patel, Tejendra, Suzuki, Oscar, Ptachcinski, Jonathan R., Armistead, Paul M., Wiltshire, Tim, Mager, Donald E., Weiner, Daniel L., Crona, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212733/ https://www.ncbi.nlm.nih.gov/pubmed/33502111 http://dx.doi.org/10.1111/cts.12956 |
Ejemplares similares
-
Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients
por: Zhu, Jing, et al.
Publicado: (2020) -
Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic
por: Zhu, Jing, et al.
Publicado: (2021) -
Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
por: Langenhorst, Jurgen B., et al.
Publicado: (2018) -
Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation
por: Shin, Seung-Hwan, et al.
Publicado: (2013) -
Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)